Patent Application
Provisional
App. No. 60/376,606
· Confirmation No. 5548
Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
Provisional Application Expired
Inventors
Debra Shade
Benbrook, TX
Allan Shepard
Fort Worth, TX
Nasreen Jacobson
Fort Worth, TX
Iok-Hou Pang
Grand Prairie, TX
Abbot F. Clark
Arlington, TX
Attorneys & Agents of Record
Prosecution
- Customer No.
- 26356
- Docket No.
- 2354 US Pr
- Confirmation No.
- 5548
Child
Claims priority from a provisional application
→
App. 10/510,585
· US 7,351,407
Filed 2004-10-08
· Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
Child
Claims priority from a provisional application
→
App. 12/970,662
Filed 2010-12-16
· Abandoned -- Failure to Respond to an Office Action
Child
Claims priority from a provisional application
→
App. 12/024,821
Filed 2008-02-01
· Abandoned -- Failure to Respond to an Office Action
Child
PCT
Claims priority from a provisional application
→
PCT/US2003/012521
Filed 2003-04-18
· PCT - IPER (International Preliminary Examination Report) 409-416 Mailed
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 60/376,606
- Filed
- 2002-04-30
External Links